FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201615851> ?p ?o ?g. }

• W3201615851 endingPage "117588" @default.
• W3201615851 startingPage "117588" @default.
• W3201615851 abstract "The formation of small hybrid aggregates between excipient and drug molecules is one of the mechanisms that contributes to the solubilization of active principles in pharmaceutical formulations. The characterization of the formation, governing interactions and structure of such entities is not trivial since they are highly flexible and dynamic, quickly exchanging molecules from one to another. In the case of cyclodextrins, this mechanism and the formation of inclusion complexes synergistically cooperate to favour the bioavailability of drugs. In a previous study we reported a detailed characterization of the possible formation of inclusion complexes with 1:1 stoichiometry between remdesivir, the only antiviral medication currently approved by the United States Food and Drug Administration for treating COVID-19, and sulphobutylether-β-cyclodextrins. Here we extend our study to assess the role of the spontaneous aggregation in the solubilization of the same drug, by molecular dynamics simulations at different relative concentrations of both compounds. The number of sulphobutylether substitutions in the cyclodextrin structure and two different protonation states of the remdesivir molecule are considered. We aim to shed light in the solubilization mechanism of sulphobutylether-β-cyclodextrins, broadly used as an excipient in many pharmaceutical formulations, in particular in the case of remdesivir as an active compound." @default.
• W3201615851 created "2021-09-27" @default.
• W3201615851 creator A5024064662 @default.
• W3201615851 creator A5033369981 @default.
• W3201615851 creator A5064618853 @default.
• W3201615851 creator A5079731596 @default.
• W3201615851 date "2021-12-01" @default.
• W3201615851 modified "2023-10-16" @default.
• W3201615851 title "Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir" @default.
• W3201615851 cites W1031578623 @default.
• W3201615851 cites W1842047525 @default.
• W3201615851 cites W1966078827 @default.
• W3201615851 cites W1980279737 @default.
• W3201615851 cites W1981021420 @default.
• W3201615851 cites W1995816895 @default.
• W3201615851 cites W2001015862 @default.
• W3201615851 cites W2023790710 @default.
• W3201615851 cites W2035687084 @default.
• W3201615851 cites W2047698253 @default.
• W3201615851 cites W2053081979 @default.
• W3201615851 cites W2057477511 @default.
• W3201615851 cites W2067174909 @default.
• W3201615851 cites W2081693079 @default.
• W3201615851 cites W2103945336 @default.
• W3201615851 cites W2128572087 @default.
• W3201615851 cites W2149107062 @default.
• W3201615851 cites W2168515966 @default.
• W3201615851 cites W2170711116 @default.
• W3201615851 cites W2306659280 @default.
• W3201615851 cites W2319963030 @default.
• W3201615851 cites W2502801021 @default.
• W3201615851 cites W2510475640 @default.
• W3201615851 cites W2586488755 @default.
• W3201615851 cites W2701237389 @default.
• W3201615851 cites W2735473913 @default.
• W3201615851 cites W2762547856 @default.
• W3201615851 cites W2766572750 @default.
• W3201615851 cites W2802328102 @default.
• W3201615851 cites W2920570109 @default.
• W3201615851 cites W2979514608 @default.
• W3201615851 cites W2988387007 @default.
• W3201615851 cites W3092761138 @default.
• W3201615851 cites W3194886549 @default.
• W3201615851 cites W4211053799 @default.
• W3201615851 doi "https://doi.org/10.1016/j.molliq.2021.117588" @default.
• W3201615851 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8447550" @default.
• W3201615851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34548723" @default.
• W3201615851 hasPublicationYear "2021" @default.
• W3201615851 type Work @default.
• W3201615851 sameAs 3201615851 @default.
• W3201615851 citedByCount "11" @default.
• W3201615851 countsByYear W32016158512022 @default.
• W3201615851 countsByYear W32016158512023 @default.
• W3201615851 crossrefType "journal-article" @default.
• W3201615851 hasAuthorship W3201615851A5024064662 @default.
• W3201615851 hasAuthorship W3201615851A5033369981 @default.
• W3201615851 hasAuthorship W3201615851A5064618853 @default.
• W3201615851 hasAuthorship W3201615851A5079731596 @default.
• W3201615851 hasBestOaLocation W32016158511 @default.
• W3201615851 hasConcept C144082473 @default.
• W3201615851 hasConcept C145148216 @default.
• W3201615851 hasConcept C178790620 @default.
• W3201615851 hasConcept C181389837 @default.
• W3201615851 hasConcept C185592680 @default.
• W3201615851 hasConcept C21951064 @default.
• W3201615851 hasConcept C2777239854 @default.
• W3201615851 hasConcept C2778649806 @default.
• W3201615851 hasConcept C2779433975 @default.
• W3201615851 hasConcept C2780035454 @default.
• W3201615851 hasConcept C30095370 @default.
• W3201615851 hasConcept C32909587 @default.
• W3201615851 hasConcept C43617362 @default.
• W3201615851 hasConcept C4863142 @default.
• W3201615851 hasConcept C55493867 @default.
• W3201615851 hasConcept C71924100 @default.
• W3201615851 hasConcept C98274493 @default.
• W3201615851 hasConceptScore W3201615851C144082473 @default.
• W3201615851 hasConceptScore W3201615851C145148216 @default.
• W3201615851 hasConceptScore W3201615851C178790620 @default.
• W3201615851 hasConceptScore W3201615851C181389837 @default.
• W3201615851 hasConceptScore W3201615851C185592680 @default.
• W3201615851 hasConceptScore W3201615851C21951064 @default.
• W3201615851 hasConceptScore W3201615851C2777239854 @default.
• W3201615851 hasConceptScore W3201615851C2778649806 @default.
• W3201615851 hasConceptScore W3201615851C2779433975 @default.
• W3201615851 hasConceptScore W3201615851C2780035454 @default.
• W3201615851 hasConceptScore W3201615851C30095370 @default.
• W3201615851 hasConceptScore W3201615851C32909587 @default.
• W3201615851 hasConceptScore W3201615851C43617362 @default.
• W3201615851 hasConceptScore W3201615851C4863142 @default.
• W3201615851 hasConceptScore W3201615851C55493867 @default.
• W3201615851 hasConceptScore W3201615851C71924100 @default.
• W3201615851 hasConceptScore W3201615851C98274493 @default.
• W3201615851 hasFunder F4320320300 @default.
• W3201615851 hasFunder F4320326655 @default.
• W3201615851 hasFunder F4320330134 @default.
• W3201615851 hasFunder F4320335322 @default.
• W3201615851 hasFunder F4320335598 @default.

• next